Hosted by Unknown Host · EN · 84 episodes
Established thought leaders with verified media credentials.
There's a scientific breakthrough in your medicine cabinet. But how did it get there? At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients. From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures. In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
Unknown Host hosts Making Medicine, a health show with 84 episodes published.
Georgia's life sciences industry is growing fast. Biotech manufacturing, clinical trials, workforce development, and healthcare policy are reshaping America's innovation economy. This week on the Making Medicine Podcast,
FDA instability is reshaping biotech investment decisions in real time. Investors are recalibrating risk, pulling back, and even shifting capital abroad. In case you missed it: We are bringing one of our most critical re
China and biotech competition. Drug pricing reform. The FDA. PBMs. America’s innovation economy. This week on the Making Medicine Podcast, John Stanford sits down with Rep. Scott Peters to discuss the future of American
What does the FDA actually look like on the inside — and why does its structure matter for drug approvals, rare disease therapies, and biotech investment? This week on the Making Medicine Podcast, host John Stanford is j
FDA instability. AI in clinical trials. China overtaking the United States in biotech development. Following news that Marty Makary has stepped down as FDA commissioner, questions around regulatory stability, scientific
Gene therapy breakthroughs. The first oral GLP-1 pill. A troubling signal for scientific talent. And a German pricing move that could quietly reshape global drug development. This week on the Making Medicine podcast, Joh
Biotech is no longer just about medicine. It is now a frontline issue in national security, global competition, and economic independence. In this episode of the Making Medicine Podcast, Senator Todd Young joins us to br
FDA instability is reshaping biotech investment decisions in real time. Investors are recalibrating risk, pulling back, and even shifting capital abroad. In this episode of the Making Medicine Podcast, John Stanford is j
FDA signals are starting to break down, and biotech is feeling it. One company is collapsing while another is breaking through. As lawmakers return to Washington for a packed schedule of healthcare hearings, the conversa
Tariffs, MFN pricing, and FDA delays are colliding, and small biotech is paying the price. One company already collapsed. More could follow. In this episode, we break down how Section 232 pharmaceutical tariffs, the push
Last week, seven leading life sciences investors went to Washington. They met with the National Security Commission on Emerging Biotechnology, walked the halls of Congress, and shared which roadblocks are preventing them
In this special re-air of the Making Medicine Podcast, we revisit a timely conversation with Dr. Michelle Rozo of the National Security Commission on Emerging Biotechnology NSCEB, originally recorded live at JPM 2026. We
With Japanese Prime Minister Sanae Takaichi meeting President Trump this week, we are re-airing our special episode from Tokyo. We explore why the U.S. delegation must prioritize a fair pricing agreement that ensures Jap
The FDA is being asked to keep pace with today's rapid scientific advancements amid ongoing resource constraints. In this episode, we unpack why regulatory predictability and *stability* matters more than ever for the fu
China has now overtaken the United States in new drug clinical trials. At the same time regulatory uncertainty and funding lapses are raising new questions about the future of the American biotech leadership. In this epi
About 90–95% of rare diseases still lack an FDA-approved treatment, underscoring the urgency for continued innovation on behalf of the estimated 30 million Americans — and families — affected by these conditions During R
FDA reversals and price controls are handing biotech dominance to China. We expose the national security crisis in drug development. The FDA is facing a crisis of confidence that threatens the stability of the entire US
TrumpRx has quickly become part of the broader drug pricing conversation, not as a new insurance program or pharmacy, but as a government website highlighting direct-to-patient cash pricing options for certain brand-name
Washington is navigating a period of significant change in health policy, with implications for how new medicines are developed, reviewed, and paid for. In this episode of Making Medicine, we take a closer look at severa
The race is being won by someone else. While the headlines focus on the prestige of JPM 2026, a much quieter and more dangerous shift is happening behind the scenes. In this special edition of The Making Medicine Podcast
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Making Medicine has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Making Medicine is hosted by Unknown Host. The show is categorised under Health (fitness) and has published 84 episodes.
Making Medicine has published 84 episodes.
Making Medicine regularly covers Health, Fitness. It sits in the Health category, with a fitness focus.
Making Medicine is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Making Medicine hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Making Medicine average 25 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Making Medicine's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.